ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

In Brief: Henney Permanent NCI Deputy Director; 17 Regional Cooperative Group Applications Get First Review

February 5, 1982

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

Final Issue of the Year

December 13, 1985

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975